Purification of opiate receptors has lagged behind that of other receptors for neurotransmitters and hormones. Thus, little is known of opiate receptor structure and its relationship to function. We propose to combine a number of approaches in order to achieve purification of kappa opiate receptors. These include affinity chromatographic, affinity labeling, and immunologic techniques. Novel, kappa-selective affinity chromatography matrices will be synthesized by attaching amine derivatives of U50-488H to activated solid supports. These columns will then be used to purify kappa receptors which retain ability to bind opiate agonists and antagonists. These columns will also be used to resolve putative U50-488H-sensitive and U50-488H-insensitive kappa receptor subtypes. Successful separation of these activities would support existence of separate kappa receptor entities. Novel electrophilic and photolabile ligands have been developed for covalent, site-directed labeling of kappa receptor proteins. These affinity probes are also based on the structure of the kappa selective agonist, U50-488H. After covalent attachment of radiolabeled probe, affinity labeled proteins will be purified by chromatographic techniques. In an alternative approach, antibodies will be raised against the appropriate kappa affinity ligand. These antibodies will then be used to isolate the corresponding covalent ligand-receptor complex. Verification that purified affinity labeled proteins are in fact kappa receptors will be obtained using an immunologic approach. Partial N-terminal sequences of the purified complexes will be obtained. Antibodies will then be raised against synthetic peptides corresponding to the sequences. These antibodies will then be tested for ability to recognize active kappa receptors. Cross-reacting antibody would confirm kappa-relatedness of the purified affinity labeled protein. Characteristics of interest in purified kappa receptors are molecular weight, isoelectric point, amino acid composition, peptide map, and sequence. Any sequence information obtained for kappa opiate receptors will be compared to known sequences of other neurotransmitter and hormone receptors.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA003776-06
Application #
3208414
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1985-06-01
Project End
1992-03-31
Budget Start
1991-04-01
Budget End
1992-03-31
Support Year
6
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Brown University
Department
Type
Schools of Medicine
DUNS #
001785542
City
Providence
State
RI
Country
United States
Zip Code
02912
Hellewell, S B; Bruce, A; Feinstein, G et al. (1994) Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol 268:9-18
Beczkowska, I W; Bowen, W D; Bodnar, R J (1992) Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in rats. Brain Res 589:291-301
Berson, D M; Graybiel, A M; Bowen, W D et al. (1991) Evidence for intrinsic expression of enkephalin-like immunoreactivity and opioid binding sites in cat superior colliculus. Neuroscience 43:513-29
Arjune, D; Bowen, W D; Bodnar, R J (1991) Ingestive behavior following central [D-Ala2, Leu5, Cys6]-enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptor. Pharmacol Biochem Behav 39:429-36
Calcagnetti, D J; Bowen, W D; Holtzman, S G (1990) Stress-induced tolerance to delta receptor agonist DPDPE and selectivity of the irreversible delta-ligand, DALCE. Brain Res 509:205-12
Hellewell, S B; Bowen, W D (1990) A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res 527:244-53
de Costa, B R; Bowen, W D; Hellewell, S B et al. (1989) Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligands. J Med Chem 32:1996-2002
Bluth, L S; Rice, K C; Jacobson, A E et al. (1989) Acylation of sigma receptors by Metaphit, an isothiocyanate derivative of phencyclidine. Eur J Pharmacol 161:273-7
Dudek, S M; Bowen, W D; Bear, M F (1989) Postnatal changes in glutamate stimulated phosphoinositide turnover in rat neocortical synaptoneurosomes. Brain Res Dev Brain Res 47:123-8
Calcagnetti, D J; Fanselow, M S; Helmstetter, F J et al. (1989) [D-Ala2,Leu5,Cys6]enkephalin: short-term agonist effects and long-term antagonism at delta opioid receptors. Peptides 10:319-26

Showing the most recent 10 out of 17 publications